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Osteoarthritis in England: Incidence Trends From National 
Health Service Hospital Episode Statistics
O. J. Morgan,1  H. J. Hillstrom,2 S. J. Ellis,2 Y. M. Golightly,3 R. Russell,4 M. T. Hannan,5  J. T. DelandIII,2 and 
R. Hillstrom1
Objective. It is typical in epidemiological research of osteoarthritis (OA) to collect data for the hand, hip, and knee. 
However, little population‐based data exist for this disease in the foot. Thus, we addressed patterns of OA for the foot 
compared with the hand, hip, and knee spanning 2000/2001 to 2017/2018 in England.
Methods. Secondary‐care data from 3 143 928 patients with OA of the foot, hand, hip, and knee were derived from 
the National Health Service (NHS) Hospital Episode Statistics (HES) database. Distribution, population prevalence, 
and incidence of joint‐specific OA were stratified by age and sex.
Results. OA incidence increased significantly at the foot [3.8% (95% confidence interval [CI] 3.0, 4.6)], hand 
[10.9% (10.1, 11.7)], hip [3.8% (2.9, 4.7)], and knee [2.9% (2.2, 3.6)] per year from 2000/2001 to 2017/2018. A higher 
proportion of women were diagnosed with OA, whereas greater incidence in men was estimated for the hand and 
hip. Foot OA presented comparable diagnosis numbers to the hand. More recently during 2012/2013 to 2017/2018, 
a significant rise in hip OA was estimated among younger adults, whereas knee OA decreased across all age groups. 
Incidence of OA in the foot and hand were particularly significant among the 75 or older age group, though bimodal 
age distributions were observed for both sites.
Conclusion. The significant increase in secondary care records for OA in England underscores the importance of 
exploring possible causative factors and identifying groups most at risk. Further detailed data may be particularly im-
portant for the hip, which represents significant incidence among younger adults. Greater incidence of OA in the foot 
compared with the knee emphasizes the need for well‐conducted epidemiological research in this area. Monitoring 
the performance of surgical outcomes at the population‐level for this frequently affected yet understudied site could 
have substantial potential to reduce the socioeconomic burden it represents to the NHS.
INTRODUCTION
Osteoarthritis (OA) represents a growing burden to the 
National Health Service (NHS) in England. The UK Chief Medi-
cal Officer has recommended investigating this disease, for which 
there is currently no cure (1). Previous estimates of hand, hip, 
and knee OA from a local database in North Staffordshire, Eng-
land, have indicated an increase in diagnoses among 35‐ to 44‐
year‐olds between 2003 and 2010 (2). However, there is limited 
up‐to‐date population‐based data of temporal trends in patient 
demographics with respect to OA in England.
Kurtz et al projected an increase in demand for the treatment 
of younger patients affected by knee and hip OA in the United 
States (3). In Sweden, incidence of OA affecting the hip and knee 
increased significantly between 1998 and 2015 (4). This was sup-
ported by W‐Dahl et al, who found that knee surgery in Swedish 
patients younger than 55 years of age doubled between 2000 
and 2010 (5). Sweden is particularly focused on registry‐based 
research, integrating public health needs into clinical strategy. 
Epidemiological OA research has concentrated on the hand, hip, 
and knee (4). Less attention has been given to the foot despite its 
inclusion in early descriptions of generalized OA (2,4,6,7).
Although few studies use the same definition to provide pop-
ulation prevalence estimates, first metatarsophalangeal (first MTP) 
joint OA appears to be the most common degenerative disease 
in the foot and ankle (7–11). Clinically referred to as hallux rigidus, 
this condition can be characterized by changes in subchondral 
bone, joint space narrowing, and focal areas of eroded cartilage, 
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resulting in severely restricted joint motion and pain (12,13). The 
frequency of hallux rigidus among middle‐aged to older adults can 
vary greatly from 6% to 39%, largely because of differences in 
age, population, and case definition (8,9).
Up‐to‐date population‐based sources are needed to better 
approximate the sex ratios and age distributions of patients with 
hallux rigidus in England and the potential burden it poses to the 
NHS. To address these gaps in knowledge, we reviewed the NHS 
Hospital Episode Statistics (HES) database, which records sec-
ondary care data for England, to ascertain population prevalence 
and incidence trends in hallux rigidus compared to first carpo-
metacarpal (first CMC), hip, and knee joint OA by sex and age 
between 2000/2001 and 2017/2018.
MATERIALS AND METHODS
Aggregate data for English NHS patients were derived from 
HES between 2000/2001 and 2017/2018 and are made publicly 
available through the National Archives (http://www.webar chives.
natio nalar chives.gov.uk). The HES database (governed by the 
Department of Health and Social Care) stores records for all NHS 
England–related admissions within a given fiscal year. It covers 
care delivered in treatment centers (including the independent sec-
tors) funded by NHS England, episodes of care in England for non‐
British residents, and privately funded patients treated within NHS 
England hospitals. Each record in the database is associated with 
a “finished consultant episode.” This refers to the duration a patient 
has spent under the care of a hospital consultant (board certified 
specialist). The HES database was accredited as a national sta-
tistic in 2008 and has been validated for research purposes (14).
The HES records included were those with the Interna-
tional Classification of Disease (ICD‐10) codes M16 (coxarthrosis 
[arthrosis of the hip]), M17 (gonarthrosis [arthrosis of the knee]), 
M18 (arthrosis of the first CMC joint), and M20.2 (hallux rigidus). 
The information associated with these ICD‐10 codes includes the 
total number of diagnoses, sex, and age. Age was calculated for 
all cases in the HES dataset, which did not discriminate between 
men and women. English population data for 2000 to 2017 were 
obtained from the Office for National Statistics UK (www.ons.gov.
uk).
Statistics. Descriptive statistics were used to report the 
distribution data for hallux rigidus, first CMC, hip, and knee joint 
OA, including totals and percentages (%). Population prevalence 
and incidence trends were computed in Joinpoint v.4.7.0.0 
(www.surve illan ce.cancer.gov/joinp oint). Joinpoint is a publicly 
available statistical software that uses regression functions to 
test whether a change in trend over time is statistically significant. 
The software provides a summary measure of trend over time by 
calculating the Average Annual Percent Change (AAPC) using 
the weighted average of the slope coefficients of the regression 
line with the weights equal to the length of each segment over 
a predetermined time period. A 95% confidence interval (CI) is 
then computed based on the normal distribution of AAPC.
Population prevalence and incidence trends in OA were esti-
mated in Joinpoint per 100 000 population in England, stratified 
by sex and age. The numerator for estimates by sex included 
each finished consultant episode divided into groups for pooled, 
men, and women, whereas the denominator consisted of the total 
English population in each calendar year. The numerator for esti-
mates by age included each finished consultant episode within 
the defined age groups, whereas the denominator consisted of 
the population of each age group for the same calendar year. A P 
value of <0.05 was used to indicate statistical significance.
Sex‐stratified incidence of OA was compiled for the entire 17‐
year period reviewed in this study; however, calculations stratified by 
age were made using data from the most recent 6 years because of 
limitations of the HES age classification system prior to 2012/2013. 
Before this period, patient age was reported within a large range; 
for example, patients aged 15 to 59 years old were calculated as a 
single group. Such a grouping would have biased the age‐stratified 
incidence calculations of OA, thus data recorded before 2012/2013 
were excluded from the regression analyses. The concurrent age 
boundaries used were those provided in the HES database.
RESULTS
Distribution of osteoarthritis (2000/2001 to 2017/2018). 
During 2000/2001 to 2017/2018, there were a total of 3 143 928 
patients presenting with OA. Based on this data, knee OA repre-
sented the greatest proportion of patients. Distribution of OA was 
higher among women for all joints examined (Table 1).
The distribution of knee and hip OA across age exhibited a 
single peak at the 70‐ to 74‐year‐old group. This distribution was 
bimodal for the first MTP and first CMC joints. Peaks at the 50‐ 
to 54‐ and 65‐ to 69‐year‐old groups were observed for the first 
MTP joint and at the 55‐ to 59‐ and 65‐to 69‐year‐old groups for 
the first CMC joint (Figure 1).
Sex‐stratified incidence of osteoarthritis 
(2000/2001 to 2017/2018). Estimated OA incidence 
increased significantly from 2000/2001 to 2017/2018 for 
every joint. Similar trends for hallux rigidus, hip, and knee OA 
were observed. The first CMC joint demonstrated compara-
Table 1. Total joint‐specific osteoarthritis diagnoses, 2000/2001 
to 2017/2018
 
Joint
First MTP First CMC Hip Knee
All (N) 60 986 88 178 1 222 446 1 772 318
Men 32% 24% 39% 43%
Women 68% 76% 61% 57%
Correction added after online publication 18 September 2019: the 
dates in the Table 1 heading have been changed to 2017/2018.
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tively higher increases (Table 2). Over more recent years, hallux 
rigidus and knee OA experienced a stabilization in diagnoses. 
The incidence of hallux rigidus was significant from 2000/2001 
to 2010/2011 [6.6% (5.5, 7.7)]. After this time, no significant 
change occurred [−0.1% (−1.5, 1.4)]. Knee OA demonstrated 
significant increases until 2007/2008 [6.7% (5.1, 8.4)], after 
which time no significant change was estimated [0.3% (−0.3, 
1.1)]. Incidence of hip OA continued to rise significantly until 
2014/2015 [4.5% (4.0, 5.1)]; this increase was not significant 
from 2015/2016 [0.3% (−4.2, 5.1)] onward. Estimated inci-
dence of first CMC joint OA was significant throughout the 17 
years reviewed (Figure 2).
Age‐stratified incidence of osteoarthritis 
(2012/2013 to 2017/2018). Between 2012/2013 and 
2017/2018, a statistically significant decline in hallux rigidus 
was estimated in the 55‐ to 64‐year‐old group. There was 
a significant rise in the incidence of patients who were 75 
years or older. The 45‐ to 54‐year‐old group also exhibited 
an increasing trend of OA, though this trend was not signifi-
cant. The incidence of first CMC joint OA was significant in the 
45‐ to 54‐year‐old group and older. There were also significant 
increases in the incidence of younger patients presenting with 
hip OA. Conversely, there were significant declines in the num-
ber of younger patients presenting with knee OA (Table 3).
DISCUSSION
The present study estimated significant increases in the 
incidence of hallux rigidus, first CMC, hip, and knee joint OA 
over a 17‐year period in England. Although women comprised 
the largest proportion of diagnoses, greater incidence in first 
CMC and hip joint OA were estimated among men. Hip OA 
represented the highest growth among younger patients, 
whereas the first CMC joint had the highest overall incidence. 
Older patients (75 years or older group) with hallux rigidus and 
Figure 1. Distribution of joint‐specific OA by age group, 2012/13‐2017/18.
 -
 200
 400
 600
 800
 1,000
 1,200
 1,400
 1,600
 1,800
 2,000
Pa
tie
nt
s
Age
2012/13 2013/14 2014/15 2015/16 2016/17 2017/18
 -
 5,000
 10,000
 15,000
 20,000
 25,000
18
20
-2
4
30
-3
4
40
-4
4
50
-5
4
60
-6
4
70
-7
4
80
-8
4
90
+
P
at
ie
nt
s
Age
Knee
 -
 200
 400
 600
 800
18
20
-2
4
30
-3
4
40
-4
4
50
-5
4
60
-6
4
70
-7
4
80
-8
4
90
+
P
at
ie
nt
s
Age
1st MTP
 -
 4,000
 8,000
 12,000
 16,000
 20,000
18
20
-2
4
30
-3
4
40
-4
4
50
-5
4
60
-6
4
70
-7
4
80
-8
4
90
+
Age
Hip
 -
 500
 1,000
 1,500
 2,000
18
20
-2
4
30
-3
4
40
-4
4
50
-5
4
60
-6
4
70
-7
4
80
-8
4
90
+
P
at
ie
nt
s
Age
1st CMC
P
at
ie
nt
s
Table 2. Incidence of joint‐specific osteoarthritis stratified by sex, 2000/20001 to 
2017/2018a
 
Joint
First MTP First CMC Hip Knee
All 3.8% (3.0, 4.6)b 10.9% (10.1, 11.7)b 3.8% (2.9, 4.7)b 2.9% (2.2, 3.6)b
Men 3.6% (2.8, 4.5)b 11.9% (10.7, 13.2)b 4.3% (3.2, 5.5)b 2.7% (2.0, 3.4)b
Women 3.9% (3.0, 4.7)b 10.7% (9.8, 11.7)b 3.8% (2.9, 4.7)b 3.1% (2.3, 3.8)b
aIn the Joinpoint regression analysis, AAPC (%) and 95% confidence interval in crude rates 
per 100 000 population were used. 
bAll values in table are statistically significant results (P value < 0.05). 
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first CMC joint OA represented the fastest growing population. 
A significant rise in the total number of patients with knee OA 
was estimated from 2000/2001 to 2017/2018; however, there 
was a higher incidence of hallux rigidus over the same time 
period.
The current findings were within the range of UK‐based 
estimates of OA (2,15). A large study by Yu et al found that 
a higher proportion of women were diagnosed with OA. The 
trend toward declined hip and knee OA later in life was also 
comparable to our results, as was a plateau in diagnoses for 
the knee since 2008/2009 (15). However, previous estimates 
of increased knee OA among 35‐ to 44‐year‐olds were not 
in agreement with our data (2). This difference can be attrib-
uted to the prior analysis of local‐level data from 1992 to 2013 
compared with our regression analyses of national‐level data 
beginning 2012/2013.
Incidence of OA in England was consistent with global trends 
(3,4,6). Analysis of a secondary care database from Sweden 
found that population growth and ageing accounted for just one‐
third of patients presenting with OA, which suggests that these 
factors do not fully explain increased incidence of the disease (4). 
Kiadaliri et al postulated that although hip OA constituted the high-
est proportion of patients in Sweden, knee OA could surpass the 
hip in coming years. In contrast, the present data suggest that 
incidence of knee OA has stabilized in England and may be over-
taken by the hip if current trends are maintained.
A significant trend in younger patients diagnosed with hip OA 
may align with recent recognition of femoroacetabular impinge-
Figure 2. Population prevalence of joint‐specific OA per 100,000 English population, 2000/01‐2017/18. [Color figure can be viewed at 
wileyonlinelibrary.com]
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Table 3. Incidence of joint‐specific osteoarthritis stratified by age, 2012/2013 to 2017/2018a
 
Joint
First MTP First CMC Hip Knee
Age group     
25‐34 −0.6% (−11.4, 11.6) 6.7% (−9.1, 25.3) 2.3% (1.5, 3.2)b −6.1% (−11.0, −0.9)b
35‐44 −4.6% (−10.1, 1.2) 1.7% (−0.9, 4.5) 2.9% (1.1, 4.8)b −7.4% (−12.1, −2.4)b
45‐54 3.8% (−0.3, 8.0) 6.6% (2.2, 11.2)b 4.2% (1.8, 6.7)b −2.1% (−5.0, 1.0)
55‐64 −2.8% (−4.0, −1.7)b 5.8% (3.8, 7.8)b 1.9% (−0.1, 4.9) −0.3% (−2.6, 2.2)
65‐74 −0.2% (−2.8, 2.5) 5.2% (2.3, 8.0)b −0.5% (−2.5, 1.6) −0.8% (−2.8, 1.3)
75+ 4.9% (1.0, 8.9)b 7.8% (43.4, 11.3)b 0.9% (−1.7, 3.6) −0.7% (−1.7, 3.2)
aIn the Joinpoint regression analysis, AAPC (%) and 95% confidence interval in crude rates per 100 000. 
bIndicates statistically significant results (P value < 0.05). 
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ment (FAI) as a precursor to hip degeneration in young adults. 
Highly active patients with features of FAI may place greater than 
normal stress on their hips, leading to mechanical damage at an 
early age (16). The potential for early onset OA in young adulthood 
can have serious implications on quality of life and the efficacy 
of conventional treatment strategies; thus, this finding warrants 
further investigation.
The observed bimodal age distributions of hallux rigidus and 
first CMC joint OA are likely the results from differences in primary 
and secondary pathways of disease. The specific reasons are 
unclear but may reflect multiple factors, such as better diagnostics 
for these conditions, improvements in referral to secondary care, 
a change in health care–seeking behavior among certain age 
groups, differences in joint injury/trauma, including heightened risk 
of falls among the elderly (17), occupation, and longevity of mod-
ern careers (18). Additional studies of patient demographics and 
populations are required to explore these potential risk factors in 
more depth.
Although population‐level data for risk factors associated 
with hand, hip, and knee OA are well documented, there is sparse 
evidence with respect to the first MTP joint, which has largely been 
excluded from OA‐based epidemiology research. The frequency 
of hallux rigidus, which has equal numbers to the first CMC joint 
OA and higher incidence than the knee, emphasizes the need for 
well‐conducted epidemiological studies of the first MTP joint to 
guide the design of future research.
Though long‐term results of joint replacement for the hip and 
knee have been made available through the National Joint Registry, 
the inability to evaluate brand‐specific first MTP and first CMC joint 
implant outcomes and survival at the population level is an obvi-
ous shortcoming in this data. Such information would be especially 
useful for the evaluation and design of the next generation of joint 
replacements. Current versions of this technology for these joints 
yield unpredictable results and unreliable longevity (19,20).
Some limitations must be considered when interpreting the 
results of this study. We were unable to account for body mass 
index, height, or other patient characteristics from the available 
data. Furthermore, utilization of secondary care data should be 
cautiously interpreted. Although it reflects a large data set across 
extended time periods, it may also reflect biases that are due to 
under‐ or overrecording practices for conditions incentivized by 
the General Medical Services as well as variable coding quality 
between different NHS trusts. However, the application of this 
large and population representative sample, which has been val-
idated for use and maintained across recent timeframes, ena-
bled comprehensive evaluation of temporal trends in OA.
In conclusion, the current study provides up‐to‐date pop-
ulation data for OA in England across a span of 17 years. The 
significant increase in secondary care records for first MTP, first 
CMC, hip, and knee joint OA underscores the importance of 
exploring possible causative factors and identifying groups most 
at risk. Further detailed information may be particularly impor-
tant for the hip, which represents a significant rise in diagno-
ses among younger adults. In highlighting the burden that hallux 
rigidus represents to the NHS with comparative data from the 
hand, hip, and knee, the results emphasize the urgent need for 
future research into the surgical outcomes and standards of care 
for underappreciated and underrecognized foot burdens at the 
population level.
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